Targeting ROS in cancer: rationale and strategies

C Glorieux, S Liu, D Trachootham… - Nature Reviews Drug …, 2024 - nature.com
Reactive oxygen species (ROS) in biological systems are transient but essential molecules
that are generated and eliminated by a complex set of delicately balanced molecular …

Fibroblasts as turned agents in cancer progression

R Wieder - Cancers, 2023 - mdpi.com
Simple Summary Normal epithelial cells in our organs are surrounded by stroma, which is
an ecosystem made up of a variety of cells and proteins that support their intended functions …

Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors

A Esmaeilzadeh, K Hadiloo, M Jabbari, R Elahi - Life Sciences, 2023 - Elsevier
Equipping cancer-fighting immune cells with chimeric antigen receptor (CAR) has gained
immense attention for cancer treatment. CAR-engineered T cells (CAR T cells) are the first …

Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing

V Gauthier, M Kyriazi, M Nefla, V Pucino… - Frontiers in …, 2023 - frontiersin.org
Fibroblasts, derived from the embryonic mesenchyme, are a diverse array of cells with roles
in development, homeostasis, repair, and disease across tissues. In doing so, fibroblasts …

Transforming cancer-associated fibroblast barrier into drug depots to boost chemo-immunotherapy in “shooting fish in a barrel” pattern

S Yuan, W Mu, S Liu, M Liu, Z Xia, S Liang, T Gao… - ACS …, 2023 - ACS Publications
The cancer-associated fibroblast (CAF) barrier in pancreatic ductal adenocarcinoma (PDAC)
greatly restricts clinical outcomes. Major obstacles to PDAC treatment include restricted …

Spatially resolved transcriptomics technology facilitates cancer research

Q Wang, Y Zhi, M Zi, Y Mo, Y Wang, Q Liao… - Advanced …, 2023 - Wiley Online Library
Single cell RNA sequencing (scRNA‐seq) provides a great convenience for studying tumor
occurrence and development for its ability to study gene expression at the individual cell …

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy

J Liu, H Tao, T Yuan, J Li, J Li, H Liang… - Frontiers in …, 2022 - frontiersin.org
Anti-PD-1/PD-L1 therapy has shown significant benefits in the treatment of a variety of
malignancies. However, not all cancer patients can benefit from this strategy due to drug …

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma

C Li, Y Yuan, X Jiang, Q Wang - Scientific Reports, 2023 - nature.com
Mounting evidence has found that tumor microenvironment (TME) plays an important role in
the tumor progression of lung adenocarcinoma (LUAD). However, the roles of tumor …

Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer

X Mao, D Zhou, K Lin, B Zhang, J Gao, F Ling… - Cancer Immunology …, 2023 - Springer
Background Tumor heterogeneity plays essential roles in developing cancer therapies,
including therapies for breast cancer (BC). In addition, it is also very important to understand …

The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma

S Bai, Y Zhao, W Chen, W Peng, Y Wang… - Journal of Translational …, 2023 - Springer
Abstract Background Cancer-associated fibroblasts (CAFs), an important component of the
tumor microenvironment (TME), play crucial roles in tumor stemness. It has been shown in …